Crosslink Capital


The Heartbeat of Private Equity and Venture CapitalCrosslink Pulse

Bigfinite Raises $8.5 Million Seed Round to Help Pharma Industry Optimize its Drug Manufacturing Process

| December 19, 2017

SAN FRANCISCODec. 19, 2017 /PRNewswire/ — Bigfinite, a provider of data analytics and AI solutions for optimizing the pharmaceutical manufacturing process, today announced that it has raised $8.5 million in a seed round of financing led by Crosslink CapitalUncork Capital (formerly SoftTech VC) and La Famiglia. Industry Ventures and Krohne also participated in the round. Omar El-Ayat, Partner, Crosslink Capital and Andy McLoughlin, Partner, Uncork Capital (formerly SoftTech VC) will join Bigfinite’s Board of Directors.

 The pharma manufacturing process yields massive amounts of data and since it comes from numerous sources, in a variety of formats, and is stored in disparate locations — it’s messy. A 2013 McKinsey report imagined a future where instead of rigid data silos that are difficult to exploit, data are captured electronically and flow easily between functions (e.g., discovery and clinical development, as well as to external partners, for instance, physicians and contract research organizations) — powering the real-time and predictive analytics that generate business value. Read rest here.
Follow Us